Filing Flows › Scribe Therapeutics (SCTX) › Next earnings date
Scribe Therapeutics (SCTX) earnings on Nov 11, 2026: what to expect
Scribe Therapeutics (SCTX) is expected to report earnings on Nov 11, 2026 (estimated), in 3 days, for the quarter ending Sep 30, 2026. Analysts expect EPS of −$1.03 (−$1.46 to −$0.75, 3 estimates) on revenue of $3.7M. It beat the EPS estimate in 100% of the quarters on record; Filing Flows' model gives it a 76% chance of beating next time.
What to watch
Last quarter (Q2 2026) the lines that make up revenue grew like this; the report shows whether the trend holds:
The last report
Scribe Therapeutics reported revenue of $1.9M for the second quarter 2026 (-61% Y/Y), net loss $6.5M. How it makes money → · Every quarter →
Scribe Therapeutics' latest quarter
Scribe Therapeutics, Q2 2026: revenue $1.9M (-61% year over year), operating margin -489.8%, net loss $6.5M. The chart follows the revenue to costs, profit and cash.
Questions
When does SCTX report earnings?
Scribe Therapeutics is expected to report on Nov 11, 2026 (estimated).
What are analysts expecting from Scribe Therapeutics?
EPS of −$1.03 and revenue of $3.7M for the quarter.
Does Scribe Therapeutics usually beat earnings?
It beat the consensus EPS estimate in 100% of the quarters on record.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.